2-cycloalkylmethyl-9,10-dihydroxy-1-(p-...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/283

C07D 217/24 (2006.01)

Patent

CA 1091675

ABSTRACT OF THE DISCLOSURE N-substituted-14-hydroxy-3-substituted-morphinan derivatives have been found to possess potent narcotic agonist or antagonist activity. In particular, the compound N-cyclo- butylmethyl-3,14-dihydroxymorphian has been found to possess potent agonist/antagonist activity as a non-narcotic analgesic. An improved total synthesis of these compounds is described herein from the starting material 2-(p-methoxybenzyl)-1,2,3,4, 5,6,7,8-octahydroisoquinoline. A preferred feature of the process involves borane reduction of 2-cyclobutylcarbonyl-9,10- dihydroxy-1-(p-methoxybenzyl)perhydroisoquinoline (Va) to provide the corresponding cyclobutylmethyl derivative complexed with borane, which forms the subject matter of this divisional specification. This intermediate is converted directly to N-cyclobutylmethyl-14.beta.-hydroxy-3-methoxymorphinan (LVa) by treating with acid.

339989

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-cycloalkylmethyl-9,10-dihydroxy-1-(p-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-cycloalkylmethyl-9,10-dihydroxy-1-(p-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-cycloalkylmethyl-9,10-dihydroxy-1-(p-... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-961043

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.